Abstract 3317: Comparative biodistribution and radiotherapeutic efficacy of the fibroblast activation protein (FAP)-targeting agents FAP-2286 and FAPI-46

成纤维细胞活化蛋白 体内分布 体内 癌症研究 IC50型 蛋白酶 医学 药代动力学 癌症 化学 分子生物学 体外 药理学 内科学 生物化学 生物 生物技术
作者
Dirk Zboralski,Aileen Hoehne,Anne Bredenbeck,Matthias Paschke,Jan Lennart von Hacht,Jim Xiao,Andrew D. Simmons,Frank Osterkamp,Thomas Harding,Minh Nguyen
出处
期刊:Cancer Research [American Association for Cancer Research]
卷期号:82 (12_Supplement): 3317-3317 被引量:3
标识
DOI:10.1158/1538-7445.am2022-3317
摘要

Abstract Background: FAP is a membrane-bound protease under investigation as a pan-cancer target given its limited expression in normal adult tissues but high expression on cancer-associated fibroblasts. FAP-2286 and FAPI-46 are radiotracers in clinical development that target FAP through different modalities: FAP-2286 employs a peptide macrocycle, whereas FAPI-46 is a quinoline-based small molecule. Here, the biochemical and cellular properties of FAP-2286 and FAPI-46 were evaluated, as well as their in vivo biodistribution and efficacy. Methods: FAP-2286 and FAPI-46 were assessed in biochemical and cellular assays for affinity to FAP and cellular uptake. Complexes of the compounds with gallium-68 (68Ga) or lutetium-177 (177Lu) were investigated in imaging and efficacy studies using the HEK-FAP xenograft mouse model. Results: FAP-2286 and FAPI-46 displayed potent affinity to human FAP by surface plasmon resonance with equilibrium dissociation constants of 1.1 and 0.04 nM, respectively. In addition, FAP-2286 and FAPI-46 inhibited human FAP protease activity with IC50 of 3.2 and 1.2 nM, respectively, and competitor binding to FAP-expressing cells with IC50 of 2.7 and 1.3 nM, respectively. In a PET imaging study, 68Ga-FAP-2286 or 68Ga-FAPI-46 resulted in comparable tumor uptake at 1 hour after injection (10 MBq; 10.6 vs 10.1 percent injected dose per gram [%ID/g]). In contrast, 177Lu-FAP-2286 and 177Lu-FAPI-46 had significant differences in tumor uptake at 24 hours (30 MBq; 15.8 vs 3.8 %ID/g, respectively; P=0.001) and 72 hours (16.4 vs 1.6 %ID/g respectively; P=0.002) after dosing as observed by SPECT imaging. Consistent with the SPECT imaging data, Alexa Fluor 488-derivatized FAP-2286 was retained in cells and secluded in endosomes out to 72 hours in vitro, whereas Alexa Fluor 488-derivatized FAPI-46 levels decreased over time starting at 8 hours, despite both showing a similar level of binding and initial internalization to HEK-FAP cells. FAP-2286 and FAPI-46 labeled with 177Lu demonstrated antitumor efficacy with mean tumor volumes (MTV) of 107 and 245 mm3, respectively, on day 9 after dosing compared with 952 mm3 for vehicle control (30 MBq; P<0.001). The suppressed tumor growth was maintained on day 23 for FAP-2286- but not for FAPI-46-treated animals (MTV 12 vs 1210 mm3; P<0.0001). At the end of the study (day 41), all mice treated with 177Lu-FAPI-46 had reached the endpoint MTV of >1500 mm³ with a median survival time (MST) of 27.5 days, whereas the MTV of mice treated with 177Lu-FAP-2286 was 106 mm3 with MST not being reached. Conclusions: In preclinical studies, the radiotherapeutic 177Lu-FAP-2286 showed longer tumor retention, resulting in greater tumor inhibition than 177Lu-FAPI-46. The phase 1/2 LuMIERE clinical trial (NCT04939610) will evaluate FAP-2286 as a therapeutic (177Lu-FAP-2286) and imaging (68Ga-FAP-2286) agent in multiple indications. Citation Format: Dirk Zboralski, Aileen Hoehne, Anne Bredenbeck, Matthias Paschke, Jan Lennart von Hacht, Jim Xiao, Andrew D. Simmons, Frank Osterkamp, Thomas Harding, Minh Nguyen. Comparative biodistribution and radiotherapeutic efficacy of the fibroblast activation protein (FAP)-targeting agents FAP-2286 and FAPI-46 [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2022; 2022 Apr 8-13. Philadelphia (PA): AACR; Cancer Res 2022;82(12_Suppl):Abstract nr 3317.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
、、、完成签到,获得积分10
1秒前
lrq完成签到,获得积分10
3秒前
古月发布了新的文献求助10
3秒前
4秒前
五六七发布了新的文献求助10
6秒前
6秒前
css1997完成签到 ,获得积分10
8秒前
无限飞丹完成签到,获得积分10
8秒前
小饭完成签到,获得积分10
8秒前
Cl1audia发布了新的文献求助10
9秒前
所所应助木可采纳,获得10
9秒前
Gyro完成签到,获得积分10
11秒前
隐形曼青应助lzx采纳,获得10
11秒前
12秒前
体贴紫完成签到,获得积分10
13秒前
13秒前
13秒前
14秒前
五六七完成签到,获得积分10
14秒前
14秒前
liz_发布了新的文献求助10
15秒前
新xin发布了新的文献求助10
16秒前
CodeCraft应助111111111采纳,获得10
17秒前
汉堡包应助秋天里的水采纳,获得10
18秒前
量子星尘发布了新的文献求助10
18秒前
Gyro发布了新的文献求助50
18秒前
慕青应助keyun采纳,获得10
18秒前
体贴紫发布了新的文献求助10
18秒前
19秒前
Dr.Who发布了新的文献求助10
20秒前
21秒前
深情安青应助科研通管家采纳,获得10
21秒前
彭于晏应助科研通管家采纳,获得10
21秒前
搜集达人应助科研通管家采纳,获得10
21秒前
顾矜应助科研通管家采纳,获得10
21秒前
华仔应助科研通管家采纳,获得10
21秒前
Owen应助科研通管家采纳,获得10
21秒前
科研通AI2S应助科研通管家采纳,获得10
22秒前
赘婿应助科研通管家采纳,获得10
22秒前
Ava应助科研通管家采纳,获得10
22秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3989444
求助须知:如何正确求助?哪些是违规求助? 3531531
关于积分的说明 11254250
捐赠科研通 3270191
什么是DOI,文献DOI怎么找? 1804901
邀请新用户注册赠送积分活动 882105
科研通“疑难数据库(出版商)”最低求助积分说明 809174